scispace - formally typeset
J

Julian Solway

Researcher at University of Chicago

Publications -  245
Citations -  12886

Julian Solway is an academic researcher from University of Chicago. The author has contributed to research in topics: Bronchoconstriction & Hyperpnea. The author has an hindex of 58, co-authored 241 publications receiving 11963 citations. Previous affiliations of Julian Solway include Brigham and Women's Hospital & University of South Dakota.

Papers
More filters
Journal ArticleDOI

A genome-wide search for asthma susceptibility loci in ethnically diverse populations

TL;DR: A genome-wide search in 140 families with ≥2 asthmatic sibs, from three racial groups and report evidence for linkage to six novel regions, including 5p15 (P= 0.0008) and 17p11.1–q11.2 (/> = 0.0015) in African Americans and 11p15 and 19q13 (P =0.0013) in Caucasians and Hispanics.
Journal ArticleDOI

Thermal mapping of the airways in humans

TL;DR: Data demonstrate that in the course of conditioning inspired air the intrathoracic and intrapulmonic airways undergo profound thermal changes that extend well into the periphery of the lung.
Journal ArticleDOI

Airway smooth muscle dynamics: A common pathway of airway obstruction in asthma

Steven S. An, +53 more
TL;DR: A central role for airway smooth muscle in the pathogenesis of airway hyperresponsiveness in asthma is explored and an attempt is made to address a fundamental abnormality of asthma, that of exaggerated airway narrowing due to excessive shortening of ASM.
Journal ArticleDOI

Allele-Specific Targeting of microRNAs to HLA-G and Risk of Asthma

TL;DR: A SNP in the 3' untranslated region of HLA-G is reported that influences the targeting of three microRNAs (miRNAs) to this gene, and it is suggested that allele-specific targeting of these miRNAs accounts, at least in part, for earlier observations on Hla-G and the risk of asthma.
Journal ArticleDOI

Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results

TL;DR: Findings appear to support a role of vitamin D status in COVID-19 risk, and randomized clinical trials are needed to determine whether broad population interventions and interventions among groups at increased risk ofitamin D deficiency and CO VID-19 could reduce COVIDs19 incidence.